Radiomics in Gastric Cancer
Description:... Gastric cancer (GC) is one of the most common malignancies worldwide. It is particularly challenging due to common detection at the advanced stages of the diseases preventing potential therapeutic and treatment strategies for patients. Common forms of treatment include chemotherapy which has been found to improve the survival rate and overall quality of life for patients with unresectable, locally advanced or at the metastatic stages of the disease. However, chemotherapy has also proven to cause significant side effects in some patients.
Lymphatic metastasis has been found to be common in gastric cancer patients. Lymph vascular invasion (LVI) has been identified to be associated to the infiltration of tumor cells in the arteries, veins or lymphatic vessels. This has been identified to prompt local recurrence and the distant metastasis of various tumors. This has led to the LVI status as an independent prognostic factor and studies have found the occurrence of pathological LVI is associated with gastric cancer progression and linked to poor clinical prognosis and low survival rate.
Show description